4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-23-020112
Director bought 7,000 shares at $1.46 ($10,220)
From the SEC's structured data for this filing
Trades in this filing
Rubin Steven D · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-25 | Purchase : show line 1 in the form | +7,000 | $1.46 | $10,220 | 7,000 | D |
| Open-market purchases · 7,000 sh · avg $1.46 · $10,220 | ||||||
Loading xslF345X04/wk-form4_1685477593.xml…